Among the first to use many newly invented devices for cerebrovascular care the neurosurgeons at our Stroke and Cerebrovascular Center of NJ continue to engage in work to help find new ways of treating strokes and aneurysms.
In an ever evolving area of care, Capital Health’s neurosciences research program includes multiple research studies including the hospital’s participation in trials only being offered at a very select number of institutions around the country.
At Capital Health our team includes neurosurgeons that are frequently among the first to use new devices and treatments including the Merci Retriever, Penumbra device and Onyx glue for aneurysms and AVMs.
Our neurosurgeons are also currently engaged in studies testing investigational devices. This includes being the only hospital in central and southern New Jersey and Philadelphia to trial Solitaire™, a new stroke device for clot removal, and the first in the country to trial an investigational device to remove blood clots in acute ischemic stroke patients, the Trevo™ device.
SUMMARY OF INVESTIGATIONAL STUDIES